Featured

RSS feed for this section

ImmusanT Finds Celiac Disease Might Be Diagnosed With A Single Gluten Challenge

ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease Symposium (ICDS) in Delhi, India for a potential blood test that could detect celiac disease with a single gluten challenge. This blood test could also […]

How Will New FDA Strategies to Evaluate Benefits vs. Risks Impact Drug Development and Approval for Celiac Disease, Non-Celiac Gluten/Wheat Sensitivity, and Their Comorbidities?

On September 18, 2017, Celiac Disease Foundation (CDF) representatives attended a Food and Drug Administration (FDA) meeting in White Oak, MD on the ongoing implementation of a benefit-risk framework to inform drug and medical device review and approval processes. Under legislative mandate, the FDA is seeking to formally incorporate the patient experience and perspective into […]

Standing Together to Help Those in Need

The tragic events in the areas affected by Hurricane Harvey have given us numerous examples of how communities can come together and support one another in a time of need. The Gluten Intolerance Group and the Celiac Disease Foundation are the trusted resources for the celiac disease and gluten-free communities. We have received many requests […]

The Lancet on Celiac Disease

On these very pages, the Celiac Disease Foundation has sought to bring you the most up-to-date information about medical research and studies in the areas of celiac disease prevalence, diagnosis, treatment, and comorbidity. In a comprehensive seminar shared with you here in both article and podcast form, co-authored by CDF Research Committee member, Benjamin Lebwohl, MD, […]